Introduction
Introduction ( 5 Questions)
A nurse is teaching a client who has Crohn's disease and is prescribed azathioprine, an antimetabolite. What should the nurse include in the teaching?
This is because azathioprine can affect the production of blood cells in your bone marrow, which are essential for fighting infections and clotting blood². Therefore, you may have a higher chance of getting infections or bleeding more easily while taking this drug. You should monitor your blood counts regularly and report any signs of infection (such as fever, sore throat, cough) or bleeding (such as bruising, nosebleeds, blood in urine or stool) to your doctor².
This is incorrect because azathioprine is not known to cause nephrotoxicity or damage to the kidneys². However, some other drugs that are used to treat IBD, such as mesalazine or sulfasalazine, may have this effect³. Therefore, you should have your kidney function checked before starting these drugs and periodically during treatment³.
This is incorrect because azathioprine is not known to cause neurotoxicity or damage to the nervous system². However, some other drugs that are used to treat IBD, such as metronidazole or ciprofloxacin, may have this effect³. Therefore, you should report any signs of neurological problems (such as numbness, tingling, weakness, vision changes, confusion) to your doctor³.
This is incorrect because azathioprine is not known to cause hepatotoxicity or damage to the liver². However, some other drugs that are used to treat IBD, such as methotrexate or 6-mercaptopurine, may have this effect³. Therefore, you should have your liver function checked before starting these drugs and periodically during treatment³.
This is because azathioprine can affect the production of blood cells in your bone marrow, which are essential for fighting infections and clotting blood². Therefore, you may have a higher chance of getting infections or bleeding more easily while taking this drug. You should monitor your blood counts regularly and report any signs of infection (such as fever, sore throat, cough) or bleeding (such as bruising, nosebleeds, blood in urine or stool) to your doctor².
The other options are incorrect because:
B. The drug may cause nephrotoxicity and increase the risk of renal impairment and electrolyte imbalances.
This is incorrect because azathioprine is not known to cause nephrotoxicity or damage to the kidneys². However, some other drugs that are used to treat IBD, such as mesalazine or sulfasalazine, may have this effect³. Therefore, you should have your kidney function checked before starting these drugs and periodically during treatment³.
C. The drug may cause neurotoxicity and increase the risk of tremor, headache, and seizures.
This is incorrect because azathioprine is not known to cause neurotoxicity or damage to the nervous system². However, some other drugs that are used to treat IBD, such as metronidazole or ciprofloxacin, may have this effect³. Therefore, you should report any signs of neurological problems (such as numbness, tingling, weakness, vision changes, confusion) to your doctor³.
D. The drug may cause hepatotoxicity and increase the risk of liver impairment and jaundice.
This is incorrect because azathioprine is not known to cause hepatotoxicity or damage to the liver². However, some other drugs that are used to treat IBD, such as methotrexate or 6-mercaptopurine, may have this effect³. Therefore, you should have your liver function checked before starting these drugs and periodically during treatment³.
